Share

April 12, 2016; 86 (15) Editorial

Sex differences in cognition

Does the “fairer sex” need a fairer test?

Mary Sano, Sam Gandy
First published March 16, 2016, DOI: https://doi.org/10.1212/WNL.0000000000002573
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
113

Share

Article Information

vol. 86 no. 15 1364-1365
DOI: 
https://doi.org/10.1212/WNL.0000000000002573
PubMed: 
26984948
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published March 16, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. Mary Sano, PhD and
    2. Sam Gandy, MD, PhD
  1. Mary Sano, PhD and
    2. Scientific Advisory Boards:

    1. Medivation, Takeda, QR Pharma, Sanofi Aventis, Eisai: Scientific Advisory Board NIA DSMB member to ASPREE study Alzheimer Association Medical and Scientific Advisory Board Member

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1)Bayer, (2)Bristol Meyer Squibb, (3)Elan, (4) Medivation (5) Medpace (6) Pfizer (7) Takeda (8)United Biosource (9) Transtech Pharma (10) F. Hoffmann-La Roche, Ltd. (10)Avaram Pharmaceuticals (11)Muses Pharmaceuticals

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH (2) VA

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Sam Gandy, MD, PhD
    3. Scientific Advisory Boards:

    1. Neurotrope (bryostatin treatment for AD)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Associate Editor, ADAD; Associate Editor, Molecular Neurodegeneration; Consulting Editor, JCI

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Avid/Lilly (donate PET ligand) Constellation Wines (grapeseed extract RCT in AD)

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From Icahn School of Medicine at Mount Sinai, New York; and Veterans Affairs Medical Center, Bronx, NY.
  1. Correspondence to Dr. Sano: mary.sano{at}mssm.edu
View Full Text

Article usage

Article usage: March 2016 to December 2022

AbstractFullPdfSource
Mar 2016532023Highwire
Apr 20165173143Highwire
May 20167217Highwire
Jun 20166513Highwire
Jul 20163205Highwire
Aug 20165300Highwire
Sep 20162821Highwire
Oct 20163700Highwire
Nov 20164411Highwire
Dec 20162722Highwire
Jan 20172811Highwire
Feb 20171613Highwire
Mar 20172200Highwire
Apr 20173511Highwire
May 20171800Highwire
Jun 20171600Highwire
Jul 20171200Highwire
Aug 20171500Highwire
Sep 20171611Highwire
Oct 20172201Highwire
Nov 20171500Highwire
Dec 20172111Highwire
Jan 2018811Highwire
Feb 2018500Highwire
Mar 20181400Highwire
Apr 20182000Highwire
May 20181401Highwire
Jun 20181200Highwire
Jul 20181600Highwire
Aug 20181601Highwire
Sep 2018700Highwire
Oct 20181001Highwire
Nov 20181600Highwire
Dec 20181400Highwire
Jan 2019800Highwire
Feb 20191000Highwire
Mar 2019900Highwire
Apr 2019400Highwire
May 2019700Highwire
Jun 2019800Highwire
Jul 2019301Highwire
Aug 2019300Highwire
Sep 2019900Highwire
Oct 2019911Highwire
Nov 20192011Highwire
Dec 20191101Highwire
Jan 2020301Highwire
Feb 2020400Highwire
Mar 2020611Highwire
Apr 2020400Highwire
May 20201210Highwire
Jun 2020911Highwire
Jul 2020710Highwire
Aug 2020200Highwire
Sep 20201310Highwire
Oct 20201600Highwire
Nov 20201210Highwire
Dec 20201810Highwire
Jan 20211200Highwire
Feb 20211800Highwire
Mar 20211810Highwire
Apr 20211410Highwire
May 20211230Highwire
Jun 2021600Highwire
Jul 20211300Highwire
Aug 20212100Highwire
Sep 20212000Highwire
Oct 20211000Highwire
Nov 20211500Highwire
Dec 20212000Highwire
Jan 2022400Highwire
Feb 20222200Highwire
Mar 2022800Highwire
Apr 20221800Highwire
May 20222345Highwire
Jun 2022700Highwire
Jul 2022112Highwire
Aug 20222122Highwire
Sep 2022700Highwire
Oct 2022700Highwire
Nov 2022900Highwire
Dec 20221300Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me